The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 02, 2016

Filed:

Sep. 26, 2012
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Lynn Abell, Washington Crossing, PA (US);

Leonard Adam, Doylestown, PA (US);

Cullen L. Cavallaro, Robbinsville, NJ (US);

Heather Finlay, Skillman, NJ (US);

Todd J. Friends, Bordentown, NJ (US);

Jon J. Hangeland, Morrisville, PA (US);

Ji Jiang, West Windsor, NJ (US);

R. Michael Lawrence, Yardley, PA (US);

Jennifer X. Qiao, Princeton, NJ (US);

Carol Hui Hu, New Hope, PA (US);

Tammy C. Wang, Lawrenceville, NJ (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/38 (2006.01); C07D 403/12 (2006.01); C07D 401/12 (2006.01); C07D 207/277 (2006.01); C07D 401/06 (2006.01); C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 409/04 (2006.01); C07D 417/04 (2006.01); C07D 417/06 (2006.01); C07D 207/28 (2006.01); C07D 233/61 (2006.01); C07D 413/06 (2006.01);
U.S. Cl.
CPC ...
C07D 207/277 (2013.01); C07D 207/28 (2013.01); C07D 207/38 (2013.01); C07D 233/61 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/06 (2013.01); C07D 409/04 (2013.01); C07D 413/06 (2013.01); C07D 417/04 (2013.01); C07D 417/06 (2013.01);
Abstract

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments. The disclosure also provides a novel method of treating diseases or conditions related to the activity of endothelial lipase by use of compounds according to Formula (II): as defined in the specification and compositions comprising any of the compounds.


Find Patent Forward Citations

Loading…